tildrakizumab: Clinical Trials

1 trial of tildrakizumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow tildrakizumab: new trials by email Literature Review of tildrakizumab trials Research Report on tildrakizumab

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Abiraterone Acetate in Combination With Tildrakizumab
Abiraterone Acetate, Tildrakizumab - Metastatic Castration Resistant Prostate Cancer
Phase 1 / Phase 2TerminatedInstitute of Cancer Research, United Kingdom132020-12-012024-04-25

Sponsors

Institute of Cancer Research, United Kingdom (1)

Countries

Switzerland (1)  ·  United Kingdom (1)

Top investigators

Johann De Bono, MD (1)